Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Ontorpacept + Doxorubicin for Leiomyosarcoma
Recruiting1 awardPhase 2
New York, New York
This trial is testing a new medicine called Ontorpacept, alone and with doxorubicin, in people with advanced leiomyosarcoma. Ontorpacept helps the immune system fight cancer, and doxorubicin kills cancer cells. The study aims to see if this combination is safe and effective.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service